Archive for April 11th, 2012
Diabetes elevates the risk of contracting tuberculosis by up to threefold, according to a study presented at the 22nd European Congress of Clinical Microbiology and Infectious Diseases. Researcher Dr. Antonio Moreno said health care providers should increase their awareness and "level of suspicion and screening" among patients with diabetes or TB.
Study: Eating fruits & veggies reduces diabetes risk
A study published in Diabetes Care found a correlation between greater consumption of fruits and vegetables and a lower risk of developing type 2 diabetes. The study, examining 3,704 participants over 11 years, also found that people who ate more vegetables and a greater variety of fruits and vegetables had less risk.
Researchers at Cornell University found the U.S. spends $190.2 billion annually for obesity-related expenditures, or about 21% of national health care costs. The findings were published in the Journal of Health Economics.
US authorities fined cosmetics and drugs giant Johnson & Johnson $70 million on Friday for bribing doctors in Europe and paying kickbacks for contracts under a UN relief program in Iraq.
Jury rules against Johnson & Johnson subsidiary in Arkansas
A Johnson & Johnson subsidiary downplayed and hid risks associated with the antipsychotic drug Risperdal, a jury determined Tuesday in Arkansas' billion-dollar lawsuit against Janssen Pharmaceuticals Inc … Arkansas' lawsuit was one of dozens of state and federal cases accusing Janssen of fraud connected with Risperdal. In January, Janssen settled with Texas for $158 million in a similar suit. Texas sought damages of about $1 billion.
The U.S. is outspending all other countries on healthcare, some $2.5 trillion in 2009. The silver lining: cancer patients in the U.S. live an average of 11 years compared with nine years in European countries. “While that sounds like good news, what I’m afraid of is that drug companies are going to read this data and see dollar signs in developing new cancer drugs that merely extend life for a short time rather than focusing on treatments that really put this horrible disease in remission,” blogger Rich Meyer writes. Although patients are living longer, their quality of life isn’t up to par. “There are far too many cancer ‘treatments’ that sell hope rather than a better quality of life and that needs to be balanced with the patient needs and wants,” he adds.
Recent evidence suggests it will not be long before low-dose aspirin is included in recommendations for preventing cancer, researchers argued.
Even a 10% reduction in the rate of all cancers within the first 10 years of treatment could make the risk-benefit ratio favorable to aspirin in people with average risk, according to Michael Thun, MD, of the American Cancer Society in Atlanta, and colleagues.